nodes	percent_of_prediction	percent_of_DWPC	metapath
Nimodipine—CYP3A4—type 2 diabetes mellitus	0.214	1	CbGaD
Nimodipine—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0421	0.146	CbGbCtD
Nimodipine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0336	0.116	CbGbCtD
Nimodipine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0299	0.104	CbGbCtD
Nimodipine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0274	0.0949	CbGbCtD
Nimodipine—CYP3A5—Losartan—type 2 diabetes mellitus	0.026	0.0901	CbGbCtD
Nimodipine—CACNA1S—pes—type 2 diabetes mellitus	0.0247	0.334	CbGeAlD
Nimodipine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0239	0.083	CbGbCtD
Nimodipine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0217	0.075	CbGbCtD
Nimodipine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0164	0.0569	CbGbCtD
Nimodipine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0157	0.0545	CbGbCtD
Nimodipine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0157	0.0545	CbGbCtD
Nimodipine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0149	0.0515	CbGbCtD
Nimodipine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0111	0.0384	CbGbCtD
Nimodipine—CYP3A4—Losartan—type 2 diabetes mellitus	0.0101	0.0351	CbGbCtD
Nimodipine—CACNA1F—retina—type 2 diabetes mellitus	0.00503	0.068	CbGeAlD
Nimodipine—CACNA1S—cardiovascular system—type 2 diabetes mellitus	0.0024	0.0324	CbGeAlD
Nimodipine—CACNB1—cardiovascular system—type 2 diabetes mellitus	0.00224	0.0302	CbGeAlD
Nimodipine—AHR—islet of Langerhans—type 2 diabetes mellitus	0.0022	0.0297	CbGeAlD
Nimodipine—CACNB2—islet of Langerhans—type 2 diabetes mellitus	0.00199	0.0269	CbGeAlD
Nimodipine—CACNB1—adipose tissue—type 2 diabetes mellitus	0.00197	0.0266	CbGeAlD
Nimodipine—CACNB3—adipose tissue—type 2 diabetes mellitus	0.00189	0.0256	CbGeAlD
Nimodipine—AHR—nephron tubule—type 2 diabetes mellitus	0.00177	0.0239	CbGeAlD
Nimodipine—CACNA1D—islet of Langerhans—type 2 diabetes mellitus	0.00174	0.0235	CbGeAlD
Nimodipine—CACNB2—retina—type 2 diabetes mellitus	0.0017	0.023	CbGeAlD
Nimodipine—AHR—pancreas—type 2 diabetes mellitus	0.00154	0.0209	CbGeAlD
Nimodipine—AHR—cortex of kidney—type 2 diabetes mellitus	0.00151	0.0205	CbGeAlD
Nimodipine—CACNB2—cardiovascular system—type 2 diabetes mellitus	0.00144	0.0195	CbGeAlD
Nimodipine—AHR—adipose tissue—type 2 diabetes mellitus	0.0014	0.0189	CbGeAlD
Nimodipine—CACNB2—cortex of kidney—type 2 diabetes mellitus	0.00137	0.0186	CbGeAlD
Nimodipine—CACNA1D—cardiovascular system—type 2 diabetes mellitus	0.00126	0.017	CbGeAlD
Nimodipine—NR3C2—retina—type 2 diabetes mellitus	0.00125	0.0169	CbGeAlD
Nimodipine—CACNA1D—pancreas—type 2 diabetes mellitus	0.00122	0.0165	CbGeAlD
Nimodipine—NR3C2—nephron tubule—type 2 diabetes mellitus	0.00118	0.0159	CbGeAlD
Nimodipine—CACNA1C—cardiovascular system—type 2 diabetes mellitus	0.00116	0.0157	CbGeAlD
Nimodipine—NR3C2—cardiovascular system—type 2 diabetes mellitus	0.00106	0.0143	CbGeAlD
Nimodipine—NR3C2—kidney—type 2 diabetes mellitus	0.00104	0.014	CbGeAlD
Nimodipine—CACNA1C—adipose tissue—type 2 diabetes mellitus	0.00103	0.0139	CbGeAlD
Nimodipine—NR3C2—cortex of kidney—type 2 diabetes mellitus	0.00101	0.0136	CbGeAlD
Nimodipine—AHR—liver—type 2 diabetes mellitus	0.000982	0.0133	CbGeAlD
Nimodipine—NR3C2—adipose tissue—type 2 diabetes mellitus	0.000933	0.0126	CbGeAlD
Nimodipine—CACNB2—liver—type 2 diabetes mellitus	0.000891	0.012	CbGeAlD
Nimodipine—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.000791	0.0107	CbGeAlD
Nimodipine—CACNA1D—liver—type 2 diabetes mellitus	0.000779	0.0105	CbGeAlD
Nimodipine—Felodipine—CALM1—type 2 diabetes mellitus	0.000676	0.106	CrCbGaD
Nimodipine—NR3C2—liver—type 2 diabetes mellitus	0.000654	0.00884	CbGeAlD
Nimodipine—Nifedipine—CALM1—type 2 diabetes mellitus	0.000654	0.103	CrCbGaD
Nimodipine—Nicardipine—CALM1—type 2 diabetes mellitus	0.000644	0.101	CrCbGaD
Nimodipine—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.000637	0.00861	CbGeAlD
Nimodipine—CYP3A5—kidney—type 2 diabetes mellitus	0.00056	0.00756	CbGeAlD
Nimodipine—CYP3A5—pancreas—type 2 diabetes mellitus	0.000556	0.00751	CbGeAlD
Nimodipine—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.000545	0.00737	CbGeAlD
Nimodipine—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.000504	0.00682	CbGeAlD
Nimodipine—Musculoskeletal discomfort—Sitagliptin—type 2 diabetes mellitus	0.000425	0.00184	CcSEcCtD
Nimodipine—Oedema—Bromocriptine—type 2 diabetes mellitus	0.000423	0.00183	CcSEcCtD
Nimodipine—CYP3A4—kidney—type 2 diabetes mellitus	0.00042	0.00568	CbGeAlD
Nimodipine—Jaundice—Irbesartan—type 2 diabetes mellitus	0.000419	0.00181	CcSEcCtD
Nimodipine—Dyspnoea—Glimepiride—type 2 diabetes mellitus	0.000418	0.00181	CcSEcCtD
Nimodipine—Nausea—Nateglinide—type 2 diabetes mellitus	0.000416	0.0018	CcSEcCtD
Nimodipine—Cardiac disorder—Valsartan—type 2 diabetes mellitus	0.000416	0.0018	CcSEcCtD
Nimodipine—Bradycardia—Metformin—type 2 diabetes mellitus	0.000416	0.0018	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.000415	0.00179	CcSEcCtD
Nimodipine—Liver function test abnormal—Ramipril—type 2 diabetes mellitus	0.000415	0.00179	CcSEcCtD
Nimodipine—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000415	0.00179	CcSEcCtD
Nimodipine—Nervous system disorder—Bromocriptine—type 2 diabetes mellitus	0.000414	0.00179	CcSEcCtD
Nimodipine—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.000413	0.00178	CcSEcCtD
Nimodipine—Hepatitis—Metformin—type 2 diabetes mellitus	0.000409	0.00177	CcSEcCtD
Nimodipine—Angiopathy—Valsartan—type 2 diabetes mellitus	0.000407	0.00176	CcSEcCtD
Nimodipine—Hepatobiliary disease—Irbesartan—type 2 diabetes mellitus	0.000406	0.00176	CcSEcCtD
Nimodipine—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000406	0.00175	CcSEcCtD
Nimodipine—Immune system disorder—Valsartan—type 2 diabetes mellitus	0.000405	0.00175	CcSEcCtD
Nimodipine—Cramp muscle—Ramipril—type 2 diabetes mellitus	0.000405	0.00175	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000404	0.00175	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000403	0.00174	CcSEcCtD
Nimodipine—Myalgia—Glyburide—type 2 diabetes mellitus	0.000403	0.00174	CcSEcCtD
Nimodipine—Immune system disorder—Orlistat—type 2 diabetes mellitus	0.0004	0.00173	CcSEcCtD
Nimodipine—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000395	0.00171	CcSEcCtD
Nimodipine—Jaundice—Losartan—type 2 diabetes mellitus	0.000394	0.0017	CcSEcCtD
Nimodipine—Anaemia—Gliclazide—type 2 diabetes mellitus	0.000393	0.0017	CcSEcCtD
Nimodipine—Bradycardia—Irbesartan—type 2 diabetes mellitus	0.000393	0.0017	CcSEcCtD
Nimodipine—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000392	0.0017	CcSEcCtD
Nimodipine—Oedema—Glyburide—type 2 diabetes mellitus	0.000386	0.00167	CcSEcCtD
Nimodipine—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000386	0.00167	CcSEcCtD
Nimodipine—Hepatitis—Irbesartan—type 2 diabetes mellitus	0.000386	0.00167	CcSEcCtD
Nimodipine—Rash—Repaglinide—type 2 diabetes mellitus	0.000383	0.00165	CcSEcCtD
Nimodipine—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000382	0.00165	CcSEcCtD
Nimodipine—Headache—Repaglinide—type 2 diabetes mellitus	0.00038	0.00164	CcSEcCtD
Nimodipine—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000379	0.00164	CcSEcCtD
Nimodipine—Flushing—Metformin—type 2 diabetes mellitus	0.000379	0.00164	CcSEcCtD
Nimodipine—Cardiac disorder—Metformin—type 2 diabetes mellitus	0.000379	0.00164	CcSEcCtD
Nimodipine—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.000379	0.00164	CcSEcCtD
Nimodipine—Sweating increased—Ramipril—type 2 diabetes mellitus	0.000379	0.00164	CcSEcCtD
Nimodipine—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.000378	0.00164	CcSEcCtD
Nimodipine—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.000377	0.00163	CcSEcCtD
Nimodipine—Palpitations—Gliclazide—type 2 diabetes mellitus	0.000376	0.00162	CcSEcCtD
Nimodipine—Muscle spasms—Valsartan—type 2 diabetes mellitus	0.000375	0.00162	CcSEcCtD
Nimodipine—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.000374	0.00161	CcSEcCtD
Nimodipine—Muscle spasms—Orlistat—type 2 diabetes mellitus	0.000371	0.0016	CcSEcCtD
Nimodipine—Angiopathy—Metformin—type 2 diabetes mellitus	0.000371	0.0016	CcSEcCtD
Nimodipine—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.00037	0.0016	CcSEcCtD
Nimodipine—Immune system disorder—Metformin—type 2 diabetes mellitus	0.000369	0.00159	CcSEcCtD
Nimodipine—Hypertension—Gliclazide—type 2 diabetes mellitus	0.000367	0.00159	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000365	0.00158	CcSEcCtD
Nimodipine—Hepatitis—Losartan—type 2 diabetes mellitus	0.000363	0.00157	CcSEcCtD
Nimodipine—Myalgia—Gliclazide—type 2 diabetes mellitus	0.000362	0.00156	CcSEcCtD
Nimodipine—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000362	0.00156	CcSEcCtD
Nimodipine—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000361	0.00156	CcSEcCtD
Nimodipine—Hypotension—Glyburide—type 2 diabetes mellitus	0.000361	0.00156	CcSEcCtD
Nimodipine—Nausea—Repaglinide—type 2 diabetes mellitus	0.00036	0.00156	CcSEcCtD
Nimodipine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000359	0.00155	CcSEcCtD
Nimodipine—Flushing—Irbesartan—type 2 diabetes mellitus	0.000358	0.00155	CcSEcCtD
Nimodipine—Cardiac disorder—Irbesartan—type 2 diabetes mellitus	0.000358	0.00155	CcSEcCtD
Nimodipine—Pruritus—Glipizide—type 2 diabetes mellitus	0.000355	0.00154	CcSEcCtD
Nimodipine—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000354	0.00153	CcSEcCtD
Nimodipine—CYP3A5—liver—type 2 diabetes mellitus	0.000354	0.00478	CbGeAlD
Nimodipine—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000352	0.00152	CcSEcCtD
Nimodipine—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.00035	0.00151	CcSEcCtD
Nimodipine—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.000348	0.00151	CcSEcCtD
Nimodipine—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000345	0.00149	CcSEcCtD
Nimodipine—Palpitations—Valsartan—type 2 diabetes mellitus	0.000345	0.00149	CcSEcCtD
Nimodipine—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000344	0.00149	CcSEcCtD
Nimodipine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000344	0.00149	CcSEcCtD
Nimodipine—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000343	0.00148	CcSEcCtD
Nimodipine—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000342	0.00148	CcSEcCtD
Nimodipine—Palpitations—Orlistat—type 2 diabetes mellitus	0.000341	0.00147	CcSEcCtD
Nimodipine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000341	0.00147	CcSEcCtD
Nimodipine—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.00034	0.00147	CcSEcCtD
Nimodipine—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.00034	0.00147	CcSEcCtD
Nimodipine—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000339	0.00146	CcSEcCtD
Nimodipine—Jaundice—Ramipril—type 2 diabetes mellitus	0.000338	0.00146	CcSEcCtD
Nimodipine—Flushing—Losartan—type 2 diabetes mellitus	0.000337	0.00146	CcSEcCtD
Nimodipine—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000335	0.00145	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000334	0.00144	CcSEcCtD
Nimodipine—Myalgia—Valsartan—type 2 diabetes mellitus	0.000333	0.00144	CcSEcCtD
Nimodipine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000332	0.00143	CcSEcCtD
Nimodipine—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000331	0.00143	CcSEcCtD
Nimodipine—Angiopathy—Losartan—type 2 diabetes mellitus	0.000329	0.00142	CcSEcCtD
Nimodipine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000329	0.00142	CcSEcCtD
Nimodipine—Myalgia—Orlistat—type 2 diabetes mellitus	0.000329	0.00142	CcSEcCtD
Nimodipine—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.000328	0.00142	CcSEcCtD
Nimodipine—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000324	0.0014	CcSEcCtD
Nimodipine—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000323	0.00139	CcSEcCtD
Nimodipine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000321	0.00139	CcSEcCtD
Nimodipine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.00032	0.00138	CcSEcCtD
Nimodipine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000319	0.00138	CcSEcCtD
Nimodipine—Oedema—Valsartan—type 2 diabetes mellitus	0.000319	0.00138	CcSEcCtD
Nimodipine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000318	0.00137	CcSEcCtD
Nimodipine—Rash—Glipizide—type 2 diabetes mellitus	0.000317	0.00137	CcSEcCtD
Nimodipine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000316	0.00137	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000316	0.00137	CcSEcCtD
Nimodipine—Oedema—Orlistat—type 2 diabetes mellitus	0.000315	0.00136	CcSEcCtD
Nimodipine—Headache—Glipizide—type 2 diabetes mellitus	0.000315	0.00136	CcSEcCtD
Nimodipine—Palpitations—Metformin—type 2 diabetes mellitus	0.000314	0.00136	CcSEcCtD
Nimodipine—Clevidipine—CYP2E1—type 2 diabetes mellitus	0.000313	0.0492	CrCbGaD
Nimodipine—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000313	0.00135	CcSEcCtD
Nimodipine—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000312	0.00135	CcSEcCtD
Nimodipine—Hepatitis—Ramipril—type 2 diabetes mellitus	0.000311	0.00134	CcSEcCtD
Nimodipine—Anaemia—Irbesartan—type 2 diabetes mellitus	0.00031	0.00134	CcSEcCtD
Nimodipine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00031	0.00134	CcSEcCtD
Nimodipine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000309	0.00134	CcSEcCtD
Nimodipine—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000309	0.00133	CcSEcCtD
Nimodipine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000309	0.00133	CcSEcCtD
Nimodipine—Nifedipine—ABCC2—type 2 diabetes mellitus	0.000308	0.0484	CrCbGaD
Nimodipine—Hypertension—Metformin—type 2 diabetes mellitus	0.000307	0.00133	CcSEcCtD
Nimodipine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000304	0.00132	CcSEcCtD
Nimodipine—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000304	0.00131	CcSEcCtD
Nimodipine—Myalgia—Metformin—type 2 diabetes mellitus	0.000303	0.00131	CcSEcCtD
Nimodipine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000301	0.0013	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.0003	0.00129	CcSEcCtD
Nimodipine—Nausea—Glipizide—type 2 diabetes mellitus	0.000298	0.00129	CcSEcCtD
Nimodipine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000298	0.00129	CcSEcCtD
Nimodipine—Hypotension—Valsartan—type 2 diabetes mellitus	0.000298	0.00129	CcSEcCtD
Nimodipine—Clevidipine—CYP1A2—type 2 diabetes mellitus	0.000298	0.0468	CrCbGaD
Nimodipine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000297	0.00128	CcSEcCtD
Nimodipine—Rash—Glimepiride—type 2 diabetes mellitus	0.000295	0.00128	CcSEcCtD
Nimodipine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000295	0.00128	CcSEcCtD
Nimodipine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000294	0.00127	CcSEcCtD
Nimodipine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000294	0.00127	CcSEcCtD
Nimodipine—Headache—Glimepiride—type 2 diabetes mellitus	0.000293	0.00127	CcSEcCtD
Nimodipine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000293	0.00126	CcSEcCtD
Nimodipine—Anaemia—Losartan—type 2 diabetes mellitus	0.000292	0.00126	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.00029	0.00126	CcSEcCtD
Nimodipine—Oedema—Metformin—type 2 diabetes mellitus	0.00029	0.00125	CcSEcCtD
Nimodipine—Hypertension—Irbesartan—type 2 diabetes mellitus	0.00029	0.00125	CcSEcCtD
Nimodipine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000289	0.00125	CcSEcCtD
Nimodipine—Flushing—Ramipril—type 2 diabetes mellitus	0.000289	0.00125	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000287	0.00124	CcSEcCtD
Nimodipine—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000286	0.00124	CcSEcCtD
Nimodipine—Nisoldipine—CYP1A2—type 2 diabetes mellitus	0.000285	0.0449	CrCbGaD
Nimodipine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000285	0.00123	CcSEcCtD
Nimodipine—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000285	0.00123	CcSEcCtD
Nimodipine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000284	0.00123	CcSEcCtD
Nimodipine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000284	0.00123	CcSEcCtD
Nimodipine—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000281	0.00121	CcSEcCtD
Nimodipine—Nilvadipine—CYP2E1—type 2 diabetes mellitus	0.000281	0.0441	CrCbGaD
Nimodipine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000281	0.00121	CcSEcCtD
Nimodipine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000279	0.00121	CcSEcCtD
Nimodipine—Palpitations—Losartan—type 2 diabetes mellitus	0.000279	0.00121	CcSEcCtD
Nimodipine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000278	0.0012	CcSEcCtD
Nimodipine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000277	0.0012	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000275	0.00119	CcSEcCtD
Nimodipine—Oedema—Irbesartan—type 2 diabetes mellitus	0.000274	0.00118	CcSEcCtD
Nimodipine—Pruritus—Glyburide—type 2 diabetes mellitus	0.000273	0.00118	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000272	0.00118	CcSEcCtD
Nimodipine—Hypotension—Metformin—type 2 diabetes mellitus	0.000271	0.00117	CcSEcCtD
Nimodipine—Myalgia—Losartan—type 2 diabetes mellitus	0.000269	0.00116	CcSEcCtD
Nimodipine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000269	0.00116	CcSEcCtD
Nimodipine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000269	0.00116	CcSEcCtD
Nimodipine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000268	0.00116	CcSEcCtD
Nimodipine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000267	0.00116	CcSEcCtD
Nimodipine—Nilvadipine—CYP1A2—type 2 diabetes mellitus	0.000267	0.042	CrCbGaD
Nimodipine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000266	0.00115	CcSEcCtD
Nimodipine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000266	0.00115	CcSEcCtD
Nimodipine—CYP3A4—liver—type 2 diabetes mellitus	0.000265	0.00359	CbGeAlD
Nimodipine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000265	0.00114	CcSEcCtD
Nimodipine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000265	0.00114	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000264	0.00114	CcSEcCtD
Nimodipine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000264	0.00114	CcSEcCtD
Nimodipine—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.00026	0.00113	CcSEcCtD
Nimodipine—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000259	0.00112	CcSEcCtD
Nimodipine—Oedema—Losartan—type 2 diabetes mellitus	0.000258	0.00111	CcSEcCtD
Nimodipine—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000256	0.00111	CcSEcCtD
Nimodipine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000256	0.0011	CcSEcCtD
Nimodipine—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000253	0.00109	CcSEcCtD
Nimodipine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000252	0.00109	CcSEcCtD
Nimodipine—Tachycardia—Losartan—type 2 diabetes mellitus	0.000252	0.00109	CcSEcCtD
Nimodipine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000251	0.00109	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000251	0.00108	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.00025	0.00108	CcSEcCtD
Nimodipine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000249	0.00108	CcSEcCtD
Nimodipine—Lercanidipine—CYP3A4—type 2 diabetes mellitus	0.000248	0.0389	CrCbGaD
Nimodipine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000246	0.00106	CcSEcCtD
Nimodipine—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000245	0.00106	CcSEcCtD
Nimodipine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000244	0.00106	CcSEcCtD
Nimodipine—Rash—Glyburide—type 2 diabetes mellitus	0.000244	0.00105	CcSEcCtD
Nimodipine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000243	0.00105	CcSEcCtD
Nimodipine—Headache—Glyburide—type 2 diabetes mellitus	0.000242	0.00105	CcSEcCtD
Nimodipine—Hypotension—Losartan—type 2 diabetes mellitus	0.000241	0.00104	CcSEcCtD
Nimodipine—Palpitations—Ramipril—type 2 diabetes mellitus	0.000239	0.00103	CcSEcCtD
Nimodipine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000237	0.00103	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000236	0.00102	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000235	0.00102	CcSEcCtD
Nimodipine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000235	0.00101	CcSEcCtD
Nimodipine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000232	0.001	CcSEcCtD
Nimodipine—Myalgia—Ramipril—type 2 diabetes mellitus	0.000231	0.000997	CcSEcCtD
Nimodipine—Amlodipine—CYP1A2—type 2 diabetes mellitus	0.00023	0.0361	CrCbGaD
Nimodipine—Dyspnoea—Losartan—type 2 diabetes mellitus	0.00023	0.000993	CcSEcCtD
Nimodipine—Nausea—Glyburide—type 2 diabetes mellitus	0.00023	0.000992	CcSEcCtD
Nimodipine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000229	0.000992	CcSEcCtD
Nimodipine—Pruritus—Valsartan—type 2 diabetes mellitus	0.000226	0.000975	CcSEcCtD
Nimodipine—Isradipine—CYP3A4—type 2 diabetes mellitus	0.000224	0.0352	CrCbGaD
Nimodipine—Pruritus—Orlistat—type 2 diabetes mellitus	0.000223	0.000963	CcSEcCtD
Nimodipine—Oedema—Ramipril—type 2 diabetes mellitus	0.000221	0.000955	CcSEcCtD
Nimodipine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000221	0.000953	CcSEcCtD
Nimodipine—Rash—Gliclazide—type 2 diabetes mellitus	0.000219	0.000945	CcSEcCtD
Nimodipine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000219	0.000945	CcSEcCtD
Nimodipine—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000218	0.000943	CcSEcCtD
Nimodipine—Headache—Gliclazide—type 2 diabetes mellitus	0.000217	0.000939	CcSEcCtD
Nimodipine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000217	0.000937	CcSEcCtD
Nimodipine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000216	0.000935	CcSEcCtD
Nimodipine—Nifedipine—CYP2E1—type 2 diabetes mellitus	0.000216	0.034	CrCbGaD
Nimodipine—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000216	0.000932	CcSEcCtD
Nimodipine—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000216	0.000931	CcSEcCtD
Nimodipine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000214	0.000924	CcSEcCtD
Nimodipine—Nicardipine—CYP2E1—type 2 diabetes mellitus	0.000213	0.0334	CrCbGaD
Nimodipine—Dizziness—Valsartan—type 2 diabetes mellitus	0.000211	0.000911	CcSEcCtD
Nimodipine—Dizziness—Orlistat—type 2 diabetes mellitus	0.000208	0.0009	CcSEcCtD
Nimodipine—Hypotension—Ramipril—type 2 diabetes mellitus	0.000207	0.000893	CcSEcCtD
Nimodipine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000206	0.000891	CcSEcCtD
Nimodipine—Nifedipine—CYP1A2—type 2 diabetes mellitus	0.000206	0.0323	CrCbGaD
Nimodipine—Pruritus—Metformin—type 2 diabetes mellitus	0.000205	0.000888	CcSEcCtD
Nimodipine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000203	0.000876	CcSEcCtD
Nimodipine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000202	0.000872	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000201	0.00087	CcSEcCtD
Nimodipine—Rash—Valsartan—type 2 diabetes mellitus	0.000201	0.000869	CcSEcCtD
Nimodipine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000201	0.000868	CcSEcCtD
Nimodipine—Vomiting—Orlistat—type 2 diabetes mellitus	0.0002	0.000866	CcSEcCtD
Nimodipine—Headache—Valsartan—type 2 diabetes mellitus	0.0002	0.000863	CcSEcCtD
Nimodipine—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000199	0.000858	CcSEcCtD
Nimodipine—Rash—Orlistat—type 2 diabetes mellitus	0.000199	0.000858	CcSEcCtD
Nimodipine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000198	0.000858	CcSEcCtD
Nimodipine—Headache—Orlistat—type 2 diabetes mellitus	0.000197	0.000853	CcSEcCtD
Nimodipine—Clevidipine—CYP3A4—type 2 diabetes mellitus	0.000197	0.031	CrCbGaD
Nimodipine—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000197	0.000852	CcSEcCtD
Nimodipine—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000194	0.000838	CcSEcCtD
Nimodipine—Dizziness—Metformin—type 2 diabetes mellitus	0.000192	0.00083	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000191	0.000825	CcSEcCtD
Nimodipine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.00019	0.000821	CcSEcCtD
Nimodipine—Nausea—Valsartan—type 2 diabetes mellitus	0.000189	0.000818	CcSEcCtD
Nimodipine—Nisoldipine—CYP3A4—type 2 diabetes mellitus	0.000189	0.0297	CrCbGaD
Nimodipine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000187	0.00081	CcSEcCtD
Nimodipine—Nausea—Orlistat—type 2 diabetes mellitus	0.000187	0.000809	CcSEcCtD
Nimodipine—Vomiting—Metformin—type 2 diabetes mellitus	0.000185	0.000798	CcSEcCtD
Nimodipine—Rash—Metformin—type 2 diabetes mellitus	0.000183	0.000791	CcSEcCtD
Nimodipine—Dermatitis—Metformin—type 2 diabetes mellitus	0.000183	0.00079	CcSEcCtD
Nimodipine—Pruritus—Losartan—type 2 diabetes mellitus	0.000182	0.000788	CcSEcCtD
Nimodipine—Headache—Metformin—type 2 diabetes mellitus	0.000182	0.000786	CcSEcCtD
Nimodipine—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000181	0.000783	CcSEcCtD
Nimodipine—Nitrendipine—CYP3A4—type 2 diabetes mellitus	0.000177	0.0278	CrCbGaD
Nimodipine—Nilvadipine—CYP3A4—type 2 diabetes mellitus	0.000177	0.0278	CrCbGaD
Nimodipine—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000176	0.000762	CcSEcCtD
Nimodipine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000174	0.000753	CcSEcCtD
Nimodipine—Rash—Irbesartan—type 2 diabetes mellitus	0.000173	0.000746	CcSEcCtD
Nimodipine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000173	0.000746	CcSEcCtD
Nimodipine—Nausea—Metformin—type 2 diabetes mellitus	0.000172	0.000745	CcSEcCtD
Nimodipine—Headache—Irbesartan—type 2 diabetes mellitus	0.000172	0.000742	CcSEcCtD
Nimodipine—Dizziness—Losartan—type 2 diabetes mellitus	0.00017	0.000737	CcSEcCtD
Nimodipine—Vomiting—Losartan—type 2 diabetes mellitus	0.000164	0.000708	CcSEcCtD
Nimodipine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000163	0.000704	CcSEcCtD
Nimodipine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000163	0.000703	CcSEcCtD
Nimodipine—Rash—Losartan—type 2 diabetes mellitus	0.000163	0.000703	CcSEcCtD
Nimodipine—Dermatitis—Losartan—type 2 diabetes mellitus	0.000162	0.000702	CcSEcCtD
Nimodipine—Headache—Losartan—type 2 diabetes mellitus	0.000161	0.000698	CcSEcCtD
Nimodipine—Pruritus—Ramipril—type 2 diabetes mellitus	0.000156	0.000676	CcSEcCtD
Nimodipine—Nausea—Losartan—type 2 diabetes mellitus	0.000153	0.000662	CcSEcCtD
Nimodipine—Amlodipine—CYP3A4—type 2 diabetes mellitus	0.000152	0.0239	CrCbGaD
Nimodipine—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000151	0.000654	CcSEcCtD
Nimodipine—Dizziness—Ramipril—type 2 diabetes mellitus	0.000146	0.000632	CcSEcCtD
Nimodipine—Felodipine—CYP3A4—type 2 diabetes mellitus	0.000141	0.0221	CrCbGaD
Nimodipine—Vomiting—Ramipril—type 2 diabetes mellitus	0.000141	0.000607	CcSEcCtD
Nimodipine—Rash—Ramipril—type 2 diabetes mellitus	0.000139	0.000602	CcSEcCtD
Nimodipine—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000139	0.000602	CcSEcCtD
Nimodipine—Headache—Ramipril—type 2 diabetes mellitus	0.000138	0.000599	CcSEcCtD
Nimodipine—Nifedipine—CYP3A4—type 2 diabetes mellitus	0.000136	0.0214	CrCbGaD
Nimodipine—Nicardipine—CYP3A4—type 2 diabetes mellitus	0.000134	0.0211	CrCbGaD
Nimodipine—Nausea—Ramipril—type 2 diabetes mellitus	0.000131	0.000567	CcSEcCtD
Nimodipine—CYP3A5—Metabolism—CYTB—type 2 diabetes mellitus	1.78e-05	9.58e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—VEGFA—type 2 diabetes mellitus	1.78e-05	9.57e-05	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—ALB—type 2 diabetes mellitus	1.77e-05	9.55e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GCG—type 2 diabetes mellitus	1.75e-05	9.42e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—SLC2A4—type 2 diabetes mellitus	1.75e-05	9.42e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—MMP9—type 2 diabetes mellitus	1.74e-05	9.36e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SRD5A1—type 2 diabetes mellitus	1.73e-05	9.34e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—APOB—type 2 diabetes mellitus	1.73e-05	9.3e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—IL6—type 2 diabetes mellitus	1.72e-05	9.28e-05	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—TGFB1—type 2 diabetes mellitus	1.72e-05	9.28e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—NFKB1—type 2 diabetes mellitus	1.72e-05	9.27e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.72e-05	9.24e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GNB3—type 2 diabetes mellitus	1.72e-05	9.24e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—HMOX1—type 2 diabetes mellitus	1.71e-05	9.2e-05	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PIK3R1—type 2 diabetes mellitus	1.7e-05	9.13e-05	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—NOS3—type 2 diabetes mellitus	1.7e-05	9.13e-05	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—EGFR—type 2 diabetes mellitus	1.69e-05	9.09e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CAT—type 2 diabetes mellitus	1.69e-05	9.08e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—GSTM1—type 2 diabetes mellitus	1.68e-05	9.06e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GSTM1—type 2 diabetes mellitus	1.68e-05	9.05e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	1.66e-05	8.94e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ACACA—type 2 diabetes mellitus	1.65e-05	8.91e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—STAR—type 2 diabetes mellitus	1.65e-05	8.91e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—HSD17B3—type 2 diabetes mellitus	1.65e-05	8.91e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—LPL—type 2 diabetes mellitus	1.65e-05	8.88e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—APOB—type 2 diabetes mellitus	1.64e-05	8.81e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—TGFB1—type 2 diabetes mellitus	1.63e-05	8.78e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ADCY5—type 2 diabetes mellitus	1.61e-05	8.7e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GPX1—type 2 diabetes mellitus	1.61e-05	8.67e-05	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—TNF—type 2 diabetes mellitus	1.61e-05	8.66e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—SRC—type 2 diabetes mellitus	1.6e-05	8.63e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—EGFR—type 2 diabetes mellitus	1.6e-05	8.61e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GSTM1—type 2 diabetes mellitus	1.59e-05	8.57e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ABCC8—type 2 diabetes mellitus	1.59e-05	8.54e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CBS—type 2 diabetes mellitus	1.59e-05	8.54e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CD36—type 2 diabetes mellitus	1.57e-05	8.44e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—LPL—type 2 diabetes mellitus	1.56e-05	8.41e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—VEGFA—type 2 diabetes mellitus	1.56e-05	8.41e-05	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PTGS2—type 2 diabetes mellitus	1.55e-05	8.35e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.55e-05	8.34e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ADCY5—type 2 diabetes mellitus	1.53e-05	8.24e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SLC5A2—type 2 diabetes mellitus	1.53e-05	8.22e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—COX2—type 2 diabetes mellitus	1.53e-05	8.22e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GPX1—type 2 diabetes mellitus	1.52e-05	8.21e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—TNF—type 2 diabetes mellitus	1.52e-05	8.2e-05	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—IL6—type 2 diabetes mellitus	1.51e-05	8.15e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—IL6—type 2 diabetes mellitus	1.51e-05	8.15e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GNB3—type 2 diabetes mellitus	1.51e-05	8.12e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.51e-05	8.12e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—HMOX1—type 2 diabetes mellitus	1.5e-05	8.08e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NCOA6—type 2 diabetes mellitus	1.5e-05	8.08e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—MTHFR—type 2 diabetes mellitus	1.49e-05	8e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CD36—type 2 diabetes mellitus	1.48e-05	7.99e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CAT—type 2 diabetes mellitus	1.48e-05	7.98e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—UCP2—type 2 diabetes mellitus	1.47e-05	7.94e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—UCP3—type 2 diabetes mellitus	1.47e-05	7.94e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—HSD11B1—type 2 diabetes mellitus	1.47e-05	7.94e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PPP2CA—type 2 diabetes mellitus	1.47e-05	7.89e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PPARA—type 2 diabetes mellitus	1.46e-05	7.85e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—APOB—type 2 diabetes mellitus	1.44e-05	7.74e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—TGFB1—type 2 diabetes mellitus	1.43e-05	7.72e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—AGT—type 2 diabetes mellitus	1.41e-05	7.6e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—MTHFR—type 2 diabetes mellitus	1.41e-05	7.58e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—EGFR—type 2 diabetes mellitus	1.4e-05	7.57e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GSTM1—type 2 diabetes mellitus	1.4e-05	7.53e-05	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—AKT1—type 2 diabetes mellitus	1.4e-05	7.52e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CALM1—type 2 diabetes mellitus	1.39e-05	7.47e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PCK1—type 2 diabetes mellitus	1.39e-05	7.46e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—APOE—type 2 diabetes mellitus	1.38e-05	7.45e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PPARA—type 2 diabetes mellitus	1.38e-05	7.43e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—LPL—type 2 diabetes mellitus	1.37e-05	7.39e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—APOA1—type 2 diabetes mellitus	1.37e-05	7.36e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ADCY5—type 2 diabetes mellitus	1.34e-05	7.24e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GPX1—type 2 diabetes mellitus	1.34e-05	7.21e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—TNF—type 2 diabetes mellitus	1.34e-05	7.21e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—AGT—type 2 diabetes mellitus	1.34e-05	7.2e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CALM1—type 2 diabetes mellitus	1.31e-05	7.08e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—APOE—type 2 diabetes mellitus	1.31e-05	7.05e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CD36—type 2 diabetes mellitus	1.3e-05	7.02e-05	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—IL6—type 2 diabetes mellitus	1.3e-05	6.99e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—HK1—type 2 diabetes mellitus	1.3e-05	6.99e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—APOA1—type 2 diabetes mellitus	1.29e-05	6.97e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PPP2CA—type 2 diabetes mellitus	1.29e-05	6.94e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	1.28e-05	6.91e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—LPA—type 2 diabetes mellitus	1.25e-05	6.75e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—KCNJ11—type 2 diabetes mellitus	1.25e-05	6.75e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GCKR—type 2 diabetes mellitus	1.25e-05	6.75e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—HSD3B2—type 2 diabetes mellitus	1.25e-05	6.75e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—MTHFR—type 2 diabetes mellitus	1.24e-05	6.66e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—IL6—type 2 diabetes mellitus	1.23e-05	6.62e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PPARA—type 2 diabetes mellitus	1.21e-05	6.53e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PPARG—type 2 diabetes mellitus	1.2e-05	6.49e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ALDOB—type 2 diabetes mellitus	1.2e-05	6.47e-05	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—AKT1—type 2 diabetes mellitus	1.2e-05	6.45e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—INS—type 2 diabetes mellitus	1.18e-05	6.36e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—AGT—type 2 diabetes mellitus	1.17e-05	6.32e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CALM1—type 2 diabetes mellitus	1.15e-05	6.22e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—APOE—type 2 diabetes mellitus	1.15e-05	6.2e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PPARG—type 2 diabetes mellitus	1.14e-05	6.14e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—APOA1—type 2 diabetes mellitus	1.14e-05	6.13e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—AKT1—type 2 diabetes mellitus	1.13e-05	6.11e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.12e-05	6.04e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.12e-05	6.04e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—INS—type 2 diabetes mellitus	1.12e-05	6.03e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GLP1R—type 2 diabetes mellitus	1.12e-05	6.02e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ALB—type 2 diabetes mellitus	1.08e-05	5.83e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—IL6—type 2 diabetes mellitus	1.08e-05	5.82e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.06e-05	5.73e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.06e-05	5.73e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SLC2A2—type 2 diabetes mellitus	1.04e-05	5.62e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.04e-05	5.58e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—NOS3—type 2 diabetes mellitus	1.04e-05	5.58e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ALB—type 2 diabetes mellitus	1.03e-05	5.52e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—MTR—type 2 diabetes mellitus	1.02e-05	5.5e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CPT1A—type 2 diabetes mellitus	1.02e-05	5.5e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.01e-05	5.46e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PPARG—type 2 diabetes mellitus	1e-05	5.4e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NAMPT—type 2 diabetes mellitus	1e-05	5.4e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—AKT1—type 2 diabetes mellitus	9.96e-06	5.37e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—LIPC—type 2 diabetes mellitus	9.96e-06	5.36e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GCK—type 2 diabetes mellitus	9.96e-06	5.36e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—HBA1—type 2 diabetes mellitus	9.96e-06	5.36e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP11A1—type 2 diabetes mellitus	9.89e-06	5.33e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—INS—type 2 diabetes mellitus	9.83e-06	5.29e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—NOS3—type 2 diabetes mellitus	9.81e-06	5.28e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PIK3R1—type 2 diabetes mellitus	9.81e-06	5.28e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SLC9A1—type 2 diabetes mellitus	9.72e-06	5.23e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CETP—type 2 diabetes mellitus	9.6e-06	5.17e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PTGS2—type 2 diabetes mellitus	9.47e-06	5.1e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	9.36e-06	5.04e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	9.36e-06	5.04e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	9.04e-06	4.87e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	9.04e-06	4.87e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	9.04e-06	4.87e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	9.04e-06	4.87e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	9.04e-06	4.87e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ALB—type 2 diabetes mellitus	9.01e-06	4.85e-05	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—AKT1—type 2 diabetes mellitus	9e-06	4.85e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PTGS2—type 2 diabetes mellitus	8.97e-06	4.83e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SNAP25—type 2 diabetes mellitus	8.93e-06	4.81e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SREBF1—type 2 diabetes mellitus	8.93e-06	4.81e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PSMD6—type 2 diabetes mellitus	8.93e-06	4.81e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CTGF—type 2 diabetes mellitus	8.76e-06	4.72e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	8.76e-06	4.72e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—HMGCR—type 2 diabetes mellitus	8.69e-06	4.68e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—NOS3—type 2 diabetes mellitus	8.62e-06	4.64e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PIK3R1—type 2 diabetes mellitus	8.62e-06	4.64e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ADRA2A—type 2 diabetes mellitus	8.5e-06	4.58e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	8.27e-06	4.45e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	8.27e-06	4.45e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP2E1—type 2 diabetes mellitus	8.17e-06	4.4e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP1A2—type 2 diabetes mellitus	8.08e-06	4.35e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SLC2A1—type 2 diabetes mellitus	8.08e-06	4.35e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	8.06e-06	4.34e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PTGS2—type 2 diabetes mellitus	7.88e-06	4.25e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP3A4—type 2 diabetes mellitus	7.87e-06	4.24e-05	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—AKT1—type 2 diabetes mellitus	7.79e-06	4.2e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SLC2A4—type 2 diabetes mellitus	7.74e-06	4.17e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GCG—type 2 diabetes mellitus	7.74e-06	4.17e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	7.69e-06	4.14e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	7.69e-06	4.14e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	7.69e-06	4.14e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	7.37e-06	3.97e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	7.37e-06	3.97e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	7.09e-06	3.82e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	7.09e-06	3.82e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	6.97e-06	3.75e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	6.85e-06	3.69e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	6.85e-06	3.69e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	6.85e-06	3.69e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GNB3—type 2 diabetes mellitus	6.67e-06	3.59e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.67e-06	3.59e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—HMOX1—type 2 diabetes mellitus	6.64e-06	3.58e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CAT—type 2 diabetes mellitus	6.55e-06	3.53e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	6.44e-06	3.47e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—APOB—type 2 diabetes mellitus	6.36e-06	3.43e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTM1—type 2 diabetes mellitus	6.19e-06	3.33e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—LPL—type 2 diabetes mellitus	6.08e-06	3.27e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	6.03e-06	3.25e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ADCY5—type 2 diabetes mellitus	5.95e-06	3.2e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GPX1—type 2 diabetes mellitus	5.93e-06	3.19e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	5.83e-06	3.14e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	5.83e-06	3.14e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	5.83e-06	3.14e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	5.83e-06	3.14e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	5.77e-06	3.11e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	5.7e-06	3.07e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	5.59e-06	3.01e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	5.47e-06	2.95e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	5.37e-06	2.89e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	5.2e-06	2.8e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	5.19e-06	2.8e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	5.11e-06	2.75e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	5.09e-06	2.74e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	5.03e-06	2.71e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	4.85e-06	2.61e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—AKT1—type 2 diabetes mellitus	4.76e-06	2.56e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	4.75e-06	2.56e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	4.75e-06	2.56e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	4.66e-06	2.51e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	4.63e-06	2.49e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	4.63e-06	2.49e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	4.63e-06	2.49e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	4.6e-06	2.48e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	4.52e-06	2.43e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—AKT1—type 2 diabetes mellitus	4.51e-06	2.43e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	4.47e-06	2.41e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	4.44e-06	2.39e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	4.35e-06	2.34e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	4.15e-06	2.24e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	4.15e-06	2.24e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	4.15e-06	2.24e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	4.07e-06	2.19e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	4.04e-06	2.18e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	3.99e-06	2.15e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—AKT1—type 2 diabetes mellitus	3.96e-06	2.13e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.95e-06	2.13e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	3.82e-06	2.05e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	3.82e-06	2.05e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.8e-06	2.05e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.75e-06	2.02e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.75e-06	2.02e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.6e-06	1.94e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.6e-06	1.94e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	3.49e-06	1.88e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.1e-06	1.67e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	3.1e-06	1.67e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	3.09e-06	1.66e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	3.05e-06	1.64e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.96e-06	1.59e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.88e-06	1.55e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.82e-06	1.52e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.76e-06	1.49e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.76e-06	1.48e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.68e-06	1.45e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.65e-06	1.43e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.54e-06	1.37e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.49e-06	1.34e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.42e-06	1.3e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.38e-06	1.28e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.37e-06	1.28e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.34e-06	1.26e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.06e-06	1.11e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.02e-06	1.09e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.85e-06	9.99e-06	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.77e-06	9.55e-06	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.77e-06	9.55e-06	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	1.75e-06	9.45e-06	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.62e-06	8.74e-06	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	8.15e-07	4.39e-06	CbGpPWpGaD
